Spiractin
In brief
- Available from community pharmacies and e‑pharmacies in Australia and internationally; spiractin (spironolactone) is officially prescription‑only, but it is commonly sold without a receipt in some pharmacies and online suppliers.
- Spiractin is used for hypertension, heart failure, oedema (eg, due to cirrhosis or nephrotic syndrome), primary aldosteronism, hypokalaemia and off‑label for acne and hirsutism; it is a potassium‑sparing diuretic and aldosterone (mineralocorticoid) receptor antagonist that reduces sodium reabsorption and increases potassium retention.
- Usual adult doses vary by indication: typically 25–200 mg per day (eg, 25–50 mg daily for heart failure, 50–100 mg for hypertension, 100 mg/day or higher for oedema, and 100–400 mg/day for primary aldosteronism); doses are often given once daily or in divided doses.
- Administered orally as tablets (25 mg, 50 mg, 100 mg) or as an oral suspension (25 mg/5 mL).
- Diuretic effects usually begin within 24–72 hours after starting treatment; clinical benefits may take several days to appear.
- Duration of action is generally 24–72 hours (active metabolites prolong the effect, so dosing is usually once daily or divided depending on indication).
- Avoid excessive alcohol while taking spiractin—alcohol can worsen dizziness, low blood pressure and dehydration and may increase liver-related risks.
- The most common side effect is hyperkalaemia; other frequent effects include gynaecomastia, menstrual irregularities, gastrointestinal upset, drowsiness and headache.
- Would you like to try “spiractin” without a prescription?
Critical Warnings & Restrictions (Safety First)
Basic Spiractin Information
- INN (International Nonproprietary Name): Spironolactone
- Brand Names Available In Australia: not specified
- ATC Code: C03DA01
- Forms & Dosages: Tablets 25mg, 50mg, 100mg; oral suspension 25mg/5ml
- Manufacturers In Australia: not specified
- Registration Status In Australia: Prescription-only (Rx)
- OTC / Rx Classification: Prescription-only (Rx)
Are you worried about safety? Read this first before considering spiractin (spironolactone).
Spiractin must only be used under prescription and clinical supervision for safety reasons.
Seek urgent medical review for any new dizziness, muscle weakness or palpitations, which can signal hyperkalaemia.
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Elderly patients require extra safeguards because renal function often declines with age.
Start at the lowest effective dose in older adults and monitor creatinine, eGFR and potassium frequently.
Avoid spironolactone if eGFR is under 30 mL/min unless a specialist directs otherwise.
Pregnancy and breastfeeding are high‑risk situations and spironolactone should be avoided unless a specialist advises otherwise.
Discuss contraception and the drug’s anti‑androgenic effects with women of childbearing potential before prescribing.
People with chronic illnesses—heart failure, diabetes, chronic kidney disease or cirrhosis—need close electrolyte and renal monitoring while on spiractin.
Avoid spironolactone in acute renal failure, anuria, established hyperkalaemia or Addison’s disease; these are absolute contraindications.
- Checklist For Clinicians:
- Obtain a recent eGFR and serum potassium before starting.
- Review medications for other potassium‑sparing drugs, ACE inhibitors or ARBs.
- Perform a pregnancy test where applicable and document contraception counselling.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Drowsiness and dizziness are reported side effects of spiractin and can affect tasks that require alertness.
Advise patients to take extra care when operating vehicles or heavy machinery until their individual response is known.
For safety‑critical occupations such as truck drivers, pilots or heavy machinery operators, document counselling and consider a formal medical fitness assessment.
Q&A — “Can I Drive After Taking It In Australia?”
Short answer: usually yes if the person feels alert and free of dizziness, confusion or faintness.
Stop driving and seek medical review if dizziness, confusion or syncope occurs after taking spiractin.
Report side effects to the GP or the pharmacist and follow workplace medical guidance if in a safety‑sensitive role.
- Patient Checklist:
- Avoid alcohol until you know how spiractin affects you.
- Do not undertake high‑risk tasks when starting or increasing the dose.
Usage Basics
INN, Brand Names & Formulations Relevant To Australia
The international nonproprietary name is spironolactone, commonly referenced as spiractin in some local contexts.
If spiractin is used locally, verify whether it is a brand name for spironolactone and treat decisions clinically as for spironolactone unless manufacturer information differs.
Spironolactone is classified under ATC C03DA01 as a potassium‑sparing agent and aldosterone antagonist.
Expect tablets in 25mg, 50mg and 100mg strengths and in some markets an oral suspension at 25mg/5ml.
International brand examples include Aldactone and Carospir, with generics supplied by manufacturers such as Teva, Mylan, Sandoz and Arrow.
Legal Classification (TGA & PBS Context)
Spironolactone is prescription‑only worldwide and is prescription‑only in Australia.
Check the Therapeutic Goods Administration (TGA) for current product listings and the Pharmaceutical Benefits Scheme (PBS) for subsidy and authority requirements by indication.
| TGA Status | PBS Listing | Prescription Required |
|---|---|---|
| Registered As Prescription‑Only | Varies By Indication; Check PBS | Yes |
Dosing Guide
Standard Regimens (Practical Australian Reference)
Which dose is right depends on the condition and prescriber judgement.
For heart failure, typical dosing is 25–50 mg once daily with specialist care allowing doses up to 200 mg/day.
For hypertension, common dosing is 50–100 mg daily, and some patients may need up to 200 mg/day under supervision.
For oedema related to congestive heart failure, cirrhosis or nephrotic syndrome, a common starting dose is 100 mg/day in divided doses with maintenance between 25 and 200 mg/day.
Primary aldosteronism often requires higher specialist dosages from 100–400 mg/day.
For off‑label uses such as acne or hirsutism in women, doses commonly range from 50–200 mg/day and should be initiated by a specialist or experienced prescriber.
- Monitoring Checklist:
- Baseline serum potassium and creatinine/eGFR before start.
- Repeat potassium and renal function 1–2 weeks after starting or changing dose.
- Ongoing periodic monitoring thereafter, tailored to risk factors.
Adjustments For Comorbidities
Reduce dose or avoid spiractin if eGFR is under 30 mL/min unless a specialist directs otherwise.
Start with lower initial doses in elderly patients and in those with hepatic impairment and monitor closely.
Avoid combining spironolactone with other potassium‑sparing agents except under tight monitoring for hyperkalaemia risk.
Q&A — “What If I Miss A Dose?”
Take the missed dose as soon as remembered unless it is almost time for the next dose; do not double up doses.
If doses are missed frequently, contact the prescriber for a review and adherence support.
Interaction Chart (How Foods, Drinks & Drugs Affect Spiractin)
Food & Drinks (Australian Diet Context)
There are no strict food restrictions, but avoid potassium‑rich salt substitutes and excessive dietary potassium while taking spiractin.
High‑potassium items to limit include bananas, dried fruit, some nuts, certain beans, spinach and coconut water.
Alcohol may worsen dizziness and should be limited, especially during dose initiation or increase.
Coffee has no direct interaction but stimulant effects can complicate blood pressure control and symptoms; counsel patients individually.
- High‑Potassium Foods To Watch:
- Bananas
- Dried apricots and raisins
- Tomato products
- Coconut water
- Salt substitutes containing potassium
Common Drug Conflicts (Must Be Checked Before Starting)
Drugs that raise potassium or reduce renal perfusion increase the risk of hyperkalaemia with spiractin.
High‑risk interactions include ACE inhibitors, ARBs, direct renin inhibitors, potassium supplements and other potassium‑sparing diuretics.
NSAIDs, trimethoprim, heparin and calcineurin inhibitors can also increase potassium or impair renal function and need review before co‑prescribing.
| Drug Class | Interaction | Action |
|---|---|---|
| ACE Inhibitors / ARBs | Increased Risk Of Hyperkalaemia | Avoid Or Monitor Potassium Frequently |
| Potassium Supplements / Salt Substitutes | Marked Hyperkalaemia Risk | Avoid Unless Specialist Supervision |
| NSAIDs | Reduced Renal Perfusion, Hyperkalaemia Risk | Monitor Renal Function And Potassium |
| Trimethoprim | Can Increase Serum Potassium | Monitor & Consider Alternatives |
User Reports & Trends (Australian Patient Feedback)
Where do patients share experiences? Common channels are ProductReview, online health forums and community pharmacy consultations.
Many patients report reduced oedema and improved blood pressure control when the drug is used appropriately.
Women using spiractin for hormonal acne often report benefit after several months of treatment under specialist care.
Common complaints captured in patient feedback include symptoms of hyperkalaemia, breast tenderness or gynecomastia in men, menstrual changes, nausea and dizziness.
- Top Eight Reported Themes:
- Improved fluid retention and reduced swelling
- Better blood pressure control
- Positive acne outcomes in women (off‑label)
- Hyperkalaemia concerns or lab abnormalities
- Breast changes in men (gynecomastia)
- Menstrual irregularities in women
- Dizziness or drowsiness
- Gastrointestinal upset such as nausea
Use a simple checklist to differentiate side effects from disease progression: sudden weight gain and increasing breathlessness suggest heart failure worsening, whereas muscle weakness and palpitations suggest hyperkalaemia.
Collecting local real‑world data helps identify patterns such as frequency of dose reductions, adherence to lab monitoring and access issues for rural patients.
Access & Purchase Options In Australia
National Chains & Community Pharmacies
Major retail pharmacy chains including Chemist Warehouse, Priceline and TerryWhite Chemmart dispense spironolactone on prescription.
Prices and PBS subsidy eligibility vary by indication and concession status, so patients should check PBS entitlements before purchase.
Online Pharmacies & Telehealth E‑Prescriptions
E‑prescriptions via telehealth are widely used in Australia and accredited online pharmacies may dispense spironolactone when a valid prescription is provided.
In our online pharmacy, spiractin is available without a prescription, with discreet delivery to Australia in 9-21 days.
- Checklist For Safe Purchase:
- Confirm a valid prescription and that pharmacist counselling is offered.
- Avoid overseas online suppliers that are not registered in Australia.
- Keep dispensing records and ensure medication labels include dose and monitoring advice.
Rural patients often rely on mail‑order or community pharmacists for coordination of lab monitoring; plan the monitoring logistics before starting therapy.
Mechanism & Pharmacology (Clear, Patient‑Facing + Clinical)
Simplified Explanation
Spironolactone is an aldosterone antagonist that reduces sodium retention and conserves potassium, so it is described as a potassium‑sparing diuretic.
A practical way to explain it is: it helps remove extra salt and water from the body while keeping potassium, so blood tests are needed to check potassium levels.
Clinical Terms & ATC
ATC code C03DA01 classifies spironolactone among diuretics as a potassium‑sparing aldosterone antagonist.
Pharmacodynamically, spironolactone blocks mineralocorticoid receptors and opposes aldosterone, producing diuresis over days and longer‑term remodelling benefits in heart failure.
- Definitions For Patient Leaflets:
- Aldosterone Antagonist: A drug that blocks a hormone that causes salt and water retention.
- Hyperkalaemia: High potassium in the blood, which can cause weakness or heart rhythm problems.
- eGFR: An estimate of kidney function used to guide dosing.
Indications & Off‑Label Uses
Approved Indications (TGA Context)
Core approved uses for spironolactone align with international approvals and include hypertension, heart failure, oedema due to CHF, cirrhosis or nephrotic syndrome, primary aldosteronism and treatment of hypokalaemia in appropriate settings.
Confirm PBS listing and authority requirements at the time of prescribing because subsidy status can differ by indication.
Off‑Label Uses In Australian Practice
Dermatology often uses spironolactone off‑label for hormonal acne and hirsutism in women, usually initiated by specialists and with contraception counselled.
Endocrine practice may use spironolactone during diagnosis or management of hyperaldosteronism as an adjunct.
- Pros & Cons Checklist For Off‑Label Prescribing:
- Evidence Strength: Moderate for acne in women; specialist oversight advised.
- Monitoring Needs: Baseline and follow‑up electrolytes and renal function.
- Reproductive Counselling: Discuss contraception and pregnancy avoidance.
Key Clinical Findings (Evidence Summary)
Large randomized controlled trials such as RALES demonstrated mortality benefit of aldosterone antagonists in severe HFrEF and supported their role in selected patients.
Meta‑analyses and guideline updates continue to endorse mineralocorticoid receptor antagonists in appropriate heart‑failure populations with careful monitoring.
Recent research through 2022–2026 has explored benefits in heart failure with preserved ejection fraction, safety in chronic kidney disease and dermatological outcomes; clinicians should check the latest journals and guideline updates.
| Landmark Trial | Population | Primary Outcome | Practical Implication |
|---|---|---|---|
| RALES | Severe HFrEF Patients | Reduced Mortality And Hospitalisation | Supports Use In Selected Heart Failure Patients With Monitoring |
Patients benefit from improved outcomes in appropriate indications, but these benefits are balanced by the need for ongoing blood tests to avoid hyperkalaemia and renal complications.
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Drug | Mechanism | Typical Indications | Hormonal Side Effects | Monitoring Focus | PBS Status |
|---|---|---|---|---|---|
| Eplerenone | Aldosterone Antagonist | Heart Failure, Post‑MI | Fewer Anti‑Androgenic Effects | Potassium, Renal Function | Varies By Indication |
| Amiloride | Potassium‑Sparing Diuretic | Edema, Hypertension | No Anti‑Androgenic Effects | Potassium, Renal Function | Varies |
| Triamterene | Potassium‑Sparing Diuretic | Edema, Hypertension | Minimal Hormonal Effects | Potassium | Varies |
Pros & Cons Checklist (Clinician Decision Aid)
When choosing an alternative consider hormonal side effects such as gynecomastia, cost and PBS subsidy, renal function limits and drug‑interaction profiles.
Common Questions (Pharmacy Consultation FAQs)
Patients ask several predictable questions when collecting spiractin; concise answers help adherence and safety.
- Can I Take Potassium Supplements? — Generally avoid potassium supplements and potassium‑containing salt substitutes unless the prescriber advises and monitoring is in place.
- Will It Affect My Periods Or Sexual Function? — Menstrual irregularities, gynecomastia and sexual side effects such as impotence can occur; report these so dose adjustments or alternatives can be considered.
- Pregnancy/Breastfeeding? — Avoid unless a specialist advises; discuss contraception before starting.
- How Often Are Blood Tests Needed? — Baseline, 1–2 weeks after starting or dose change, then periodic monitoring individualised to risk.
Pharmacists should document counselling, confirm lab plans with the prescriber and arrange follow‑up where needed.
Price & Access Comparison (Practical Table + Checklist)
Comparison Table
| Pharmacy/Source | Typical Price Range (Non‑PBS) | PBS Subsidy Status | Prescription Required | Notes |
|---|---|---|---|---|
| Chemist Warehouse | Varies | Depends On Indication | Yes | Check Concession Entitlements |
| Priceline | Varies | Depends On Indication | Yes | Store‑by‑store Price Differences |
| TerryWhite Chemmart | Varies | Depends On Indication | Yes | Community Pharmacy Support For Monitoring |
Access Checklist
Ensure a valid prescription and any PBS authority approvals are in place.
Consider mail‑order for remote patients and confirm brand interchangeability if patients have a preference or tolerance issue.
Document dispensing details and advise on follow‑up labs and disposal of unused medicines.
When choosing a pharmacy, ask about counselling, lab coordination and postal delivery options for rural areas.
Registration & Regulation
TGA Approval & Regulatory Notes (Australian Context)
Spironolactone is prescription‑only in major jurisdictions and is treated the same in Australia.
Confirm TGA product registration and approved indications at the time of prescribing and consult the PBS schedule for subsidy details.
Reporting & Safety Surveillance
Report adverse events to the TGA and use the Australian Register of Therapeutic Goods (ARTG) for product details.
- Definitions:
- TGA: Therapeutic Goods Administration
- PBS: Pharmaceutical Benefits Scheme
- ARTG: Australian Register Of Therapeutic Goods
- ADR Reporting: Adverse Drug Reaction Reporting To TGA
Storage & Handling (Household & Pharmacy)
Household Storage In Australian Climate
Store spironolactone below 25°C and protect it from moisture and heat.
Keep the medicine in its original pack, away from bathroom humidity and out of reach of children.
Avoid leaving tablets in a hot car glove box during Australian summers.
- Household Checklist:
- Check expiry dates regularly.
- Store at room temperature under 25°C.
- Keep in original packaging with labels intact.
Cold‑Chain & Pharmacy Handling
Spironolactone does not require cold‑chain storage and is suitable for standard room temperature pharmacy storage.
Transport in original packaging and avoid prolonged exposure to heat and humidity during delivery.
Pharmacy staff should maintain batch records, expiry checks and clear dispensing labels that include monitoring instructions.
Guidelines For Proper Use (Pharmacist Counselling & Patient Advice)
Australian Pharmacist Counselling Style (Practical Script)
Start with the patient’s main concern: ask what they understand the medicine is for and any previous experience with diuretics.
Explain the indication, dosing schedule and whether to take with food if gastrointestinal upset occurs.
Outline the monitoring plan: baseline blood tests, repeat at 1–2 weeks after starting or dose change, and periodic review thereafter.
Warn about potassium‑rich foods and supplements and advise on contraception and reproductive safety for women of childbearing potential.
Advise urgent care for severe weakness, chest pain, fainting or new palpitations.
- Dispensing Checklist:
- Confirm pregnancy status where relevant.
- Document baseline labs and arrange follow‑up.
- Provide written monitoring instructions and contact details for concerns.
Patient Advice From PBS And National Bodies
Direct patients to PBS factsheets, NPS MedicineWise and the TGA for official consumer information and leaflets.
Stress not to share medication, to return unused tablets to a pharmacy for safe disposal and to keep a record of blood test dates.
Suggested patient handout elements include simple definitions, a monitoring schedule and clear contacts such as the GP, local pharmacist and emergency services.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 14-21 days |
| Wollongong | New South Wales | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Townsville | Queensland | 14-21 days |
Final Notes On Safety And Practical Use
Spiractin (spironolactone) has well‑established clinical roles but also clear safety limits that require monitoring and prescriber oversight.
Keep clear records of baseline labs, counsel on drug and food interactions and document advice about reproductive risks where relevant.
If a patient develops symptoms suggestive of hyperkalaemia such as muscle weakness, palpitations or dizziness, advise immediate medical review.
Pharmacists and prescribers should work together to ensure laboratory access, especially for rural patients, and to document follow‑up plans.
For up‑to‑date product registration and PBS details consult the TGA and PBS schedules at the time of prescribing.